NCT05203263View on ClinicalTrials.gov

Tolerance and Mode of Administration of Cyto-selective Cryotherapy Treatments in Face Brown Spots: Proof of Concept

NACompletedINTERVENTIONAL
Enrollment

23

Participants

Timeline

Start Date

December 15, 2021

Primary Completion Date

February 15, 2022

Study Completion Date

February 15, 2022

Conditions
Solar Lentigo
Interventions
DEVICE

(810A-v1) device prototype

Sequence with Serial Number from (810-v1 101) to (810-v1 140). Application on brown spots located on the face (6 treatments during the study).

DEVICE

(810B-v1) device prototype

Sequence with Serial Number (810-v1 141) to (810-v1 160). Application on brown spots located on the face (6 treatments during the study).

DEVICE

(810C-v1) device prototype

Sequence with Serial Number (810-v1 161) to (810-v1 200). Application on brown spots located on the face (6 treatments during the study).

Trial Locations (1)

10014

VIDNOVLENNYA medical center, Zhytomyr

Sponsors

Lead Sponsor

Cryonove Pharma

Collaborators (1)

Dermatech
All Listed Sponsors
collaborator

Dermatech

INDUSTRY

collaborator

CEISO

INDUSTRY

collaborator

INNOVSOLUTION

UNKNOWN

lead

Cryonove Pharma

INDUSTRY

NCT05203263 - Tolerance and Mode of Administration of Cyto-selective Cryotherapy Treatments in Face Brown Spots: Proof of Concept | Biotech Hunter | Biotech Hunter